Quality of health care in patients with asthma: How can be the claims data used?

Czech version

Authors: M. Prokeš; J. Suchopár; O. Suchopár
Authors‘ workplace: Drug Agency, Praha
Published in: Reviz. posud. Lék., 19, 2016, č. 4, s. 149-154
Category: Original Articles, Review Articles, Case Reports

Overview

Health insurance medication claims data contain a number of data, from which the information about the correct patient treatment can be derived. For example, three foreign studies demonstrated the identification of suboptimal asthma treatment from medication claims data databases in Canada and Sweden. When identified the physicians should be advised to get acquainted with the appropriate guidelines or with other useful information materials, which worked well in the case of potential drug-drug interactions also in the Czech Republic.

Keywords:
asthma treatment – health-care quality indicators – health insurance medical claims data

Sources

1. http://ginasthma.org/gina-reports/.

2. http://www.wikiskripta.eu/index.php/CHOPN#Etiologie_a_epidemiologie_onemocn.C4.9Bn.C3.AD

3. ČPFS, ČSAKI: Doporučený postup pro diagnostiku a léčbu bronchiál-ního astmatu. http://www.pneumologie.cz/guidelines/, vstup 28. 9. 2016.

4. Koblížek, V., Chlumský, J., Zindr, V. et al. Doporučený postup ČPFS pro diagnostiku a léčbu stabilní CHOPN. http://www.pneumologie.cz/guidelines/, vstup 28.9.2016

5. Musil, J., Fila, L., Kolek, V. Doporučený postup ČPFS pro diagnostiku a léčbu exacerbace chronické obstrukční plicní nemoci (CHOPN). http://www.pneumologie.cz/guidelines/, vstup 28. 9. 2016

6. Ahmed, S., Tamblyn, R., Winslade, N. Using decision support for population tracking of adherence to recommended asthma guidelines. BMJ Open, 2014, 4, 3, p. e003759. doi: 10.1136/bmjopen-2013-003759

7. Klomp, H. et al. Examining asthma quality of care using a population-based approach. CMAJ, 2008, 178, 8, p. 1013–1021.

8. Weidiniger, P. et al. Adherence to diagnostic guidelines and quality indicators in asthma and COPD in Swedisch primary care. Pharmacoepidemiol Drug Sa.,f 2009, 18, 5, p. 393–400.

9. Hoffmann, F. Review on use of German health insurance medication claims data of epidemiological research. Pharmacoepidemiol Drug Saf., 2009, 18, 5, p. 349–356.

10. Tran, M., Xiang, P., Rascati, K. L. et al. Predictors of appropriate pharmacotherapy managment of COPD exacerbations and impact on 6-month readmission. J. Manag. Care Spec. Pharm., 2016, 22, 10, p. 1186–1193. http://www.jmcp.org/doi/pdf/10.18553/jmcp.2016.22.10.1186

11. Prokeš, M., Pechánek, P., Soharová, T. et al. Vliv intervence VZP ČR na preskripci potenciálních lékových interakcí lékaři Královéhradeckého a Středočeského kraje. Klin. Farmakol. Farm., 2014, 28, 1, p. 8–13.

Labels

Medical assessment Occupational medicine

Assessment activities and expenditure in medical insurance

Psychological and medical aspects of medical assessment activity in history and nowadays

Impact of modern non-pharmacological treatment methods of cardiovascular diseases of cardiovascular diseases on sick leave

Article was published in

Medical Revision

2016 Issue 4